Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction between neurons and glial cells, is pleased to announce a research partnership with the University of Lyon (CERMEP), several new scientific publications and its participation in the 33rd European Congress of Neuropsychopharmacology (ECNP), due to take place from 12 to 15 September 2020.
